Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease
Clinical trial NCT03591874 · TERMINATED
Trial details
- NCT number
- NCT03591874
- Sponsor
- Ocugen
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-23
- Primary completion
- 2020-04-30
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.